Nagaileben Co., Ltd.

Equities

7447

JP3647000003

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 07:00:00 02/07/2024 BST			5-day change	1st Jan Change
2,529 ^JPY	-2.36%		-0.67%	+6.17%

06-03	Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on April 2, 2024.	CI
04-02	Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.57% for ¥1,000 million.	CI

Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on April 2, 2024.

June 03, 2024 at 07:00 am

From April 2, 2024 to May 31, 2024, the company has repurchased 125,800 shares, representing 0.4% for ¥297.11 million. With this, the company has completed the repurchase of 125,800 shares, representing 0.4% for ¥297.11 million under the buyback announced on April 2, 2024.

Latest news about Nagaileben Co., Ltd.

Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on April 2, 2024.	06-03	CI
Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.57% for ¥1,000 million.	04-02	CI
Nagaileben Co., Ltd. authorizes a Buyback Plan.	04-01	CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 2024	12-27	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2024 and the Fiscal Year Ending August 2024	12-27	CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023.	12-12	CI
Nagaileben Co., Ltd.'s Equity Buyback announced on June 29, 2023, has expired with 454,300 shares, representing 1.41% for ¥999.81 million.	12-10	CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023.	12-04	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending Feb. 2024 and the Fiscal Year Ending August 2024	02/10/23	CI
Nagaileben Co., Ltd. Announces Dividend for the Year Ended August 2023; Payable on November 27, 2023; Provides Dividend Guidance for the Year Ending August 2024	02/10/23	CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on June 29, 2023.	04/09/23	CI
Nagaileben Co., Ltd. announces an Equity Buyback for 500,000 shares, representing 1.55% for Â¥1,000 million.	29/06/23	CI
Nagaileben Co., Ltd. authorizes a Buyback Plan.	28/06/23	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023	04/04/23	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending February 2023 and Full Year Ending August 2023	27/12/22	CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending August 31, 2023	27/12/22	CI
Nagaileben Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending August 31, 2023	03/10/22	CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 31, 2023	03/10/22	CI
Nagaileben Co., Ltd. Provides consolidated Earnings guidance for the fiscal year Ending August 31, 2022	29/06/22	CI
Nagaileben Co., Ltd. Provides Dividend Guidance for the Year Ending August 31, 2022	29/06/22	CI
Tranche Update on Nagaileben Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022.	17/05/22	CI
Nagaileben Co., Ltd.'s Equity Buyback announced on May 16, 2022, has expired with 132,700 shares, representing 0.4% for ¥254.65 million.	16/05/22	CI
Nagaileben Co., Ltd. announces an Equity Buyback for 200,000 shares, representing 0.62% for ¥400 million.	16/05/22	CI
Nagaileben Co., Ltd. authorizes a Buyback Plan.	15/05/22	CI
Nagaileben's Fiscal H1 Profit Tumbles as Sales Fall	05/04/22	MT

Chart Nagaileben Co., Ltd.

Duration

Period

More charts

Company Profile

NAGAILEBEN Co., Ltd. is a Japan-based company mainly engaged in the medical wear business. The Company operates medical wear business. The medical wear business purchases and sells medical wear products used by medical professionals and care workers from subsidiaries. In addition, the Company is also engaged in the sale of shoes and other products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

28/08/2024 - Final dividend

More about the company

Income Statement Evolution

More financial data

Ratings for Nagaileben Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

2,529 JPY

Average target price

2,000 JPY

Spread / Average Target

-20.92%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Supplies

	1st Jan change	Capi.
NAGAILEBEN CO., LTD.	+6.17%	508M
COLOPLAST A/S	+8.34%	26.91B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+19.18%	2.48B
HARTALEGA HOLDINGS	+22.96%	2.43B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-52.17%	2.18B
WINNER MEDICAL CO., LTD.	-31.25%	2.06B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-18.53%	1.75B
NAKANISHI INC.	+7.38%	1.33B
KOSSAN RUBBER INDUSTRIES	+29.73%	1.3B
GVS S.P.A.	+14.26%	1.25B

Medical Supplies